Cartilage Gel

About ACS-Biotech

ACS Biotech is a private, clinical-stage biotech firm developing a novel, cell-based cartilage gel for the repair of articular cartilage defects. Its core technology is a patented, physically crosslinked 3D chitosan hydrogel matrix that serves as a biomimetic scaffold for chondrocytes. The company is preparing for clinical trials for its lead product while generating early revenue through its research products and biobanking services. Based in Lyon, France, it leverages a team and scientific board with deep expertise in biomaterials, cartilage biology, and orthopaedic surgery.

Therapeutic Areas